Nörokütan Hastalıklarda Görüntüleme Bulguları

Neurocutaneous Disorders. Rosser Tena. Child Neurology. 2018:24;96-129.

Nörokutanöz Hastalıklar. Ö Kızılca, Kır M.J Pediatr Sci. 2015:11; 105-111.

The Phakomatoses. G, Vezina Ve AJ, Barkovich. Barkovich AJ, Raybaud C, Editors. Pediatric Neuroimaging..2012: 569-636.

Neurocutaneus Disorders. Vezina G, Barkovich AJ. Barkovich AJ, Raybaud C, Eds. Pediatric, 2012: 859-954.

Genetic Linkage of Von Recklinghausen Neurofibromatosis to the Nerve Growth Factor Receptor Gene. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH,Faryniarz AG, Chao MV. 1987:589-594.

The Rasopathies: Developmental Syndromes of Ras/Mapk Pathway Dysregulation. Tidyman We, Rauen Ka. 2009: 230-236.

Neurofibromatosis-Conference Statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988: 575-8.

MR İmaging of Optic Pathways In Patients With Neurofibromatosis. Brown EW, Riccardi VM, Mawad M, Handel S,Goldman A, Bryan RN. 1987: 1031-1036.

Nörokutan Hastalıklarda Nöroradyolojık Değerlendirme. Fadime G, Okan Ç.Temel Pediatrik Nöroloji Tanı ve Tedavi. 2022: 993-1002.

Spontaneous Regression of Optic Pathways Gliomas In Three Patients with Neurofibromatosis Type I And Critical Review of the Literature. Piccirilli M, Lenzi J, Delfinis C, Trasimeni G, Salvati M,Raco A. Childs Nerv Syst. 2006: 22: 1332-7.

Brainstem Lesions In Neurofibromatosis Type 1. Ullrich NJ, Raja AI, Irons MB, Kieran MW,Goumnerova L. Neurosurgery. 2007:61; 762-6.

Fakomatozlar. Sığırcı A. 2019:Trd Sem , 342-356.

Neuroimaging Manifestations of NT1:-Pictorial Review. O'Brien WT. J Am Osteopath Coll Radiol.

Neurofibromas with İmaging Characteristics Resembling Vascular Anomalies. Yilmaz S, Ozolek JA, Zammerilla LL, Fitz CR,Grunwaldt LJ, Crowley JJ. 2014: AJR Am J Roentgenol, 697-705.

Paediatric Presentation of Type 2 Neurofibromatosis. Evans D, Birch J, Ramsden R. 1999: Arch Dis Child, 496-9.

The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Viskochil D. JAMA 1997:273; 51-57.

Asthagiri AR, Parry DM, Butman JA. Neurofibromatosis Type 2. Lancet .2009:373; 1974-86.

Fakomatozlar. Arslan U, Dürük K. T Klin Oft . 2013:2;170-180.

Schwannomatosis:The Overlooked Neurofibromatosis? Koontz Na, Wiens AL, Agarwal A, Hingtgen CM, Emerson RE, Mosier KM. AJR Am J Roentgenol. 2013: 200;646-53.

Pictorial Review of Tuberous Sclerosis In Various Organs. Umeoka S, Koyama T, Miki Y, Akai M, Tsutsui K, Togashi K. Radiographics. 2000:28; 32.

Tuberous Sclerosis Consensus Conference:Recommendations For Diagnostic Evaluation. Roach ES, Dimario FJ, Kandt RS, Northrup H. National Tuberous Sclerosis Association. J.Child Neurol. 1999: 14;401-7.

International Tuberous Sclerosis Complex Consensus Group. Tuberous Sclerosis Complex Diagnostic Criteria Update:Recommendations of the 2012 İnternational Tuberous Sclerosis Complex Consensus Conference. Northrup H, Krueger DA. Pediatr Neuol. 2013:49; 243-54.

Kalıtsal Nörokutanöz Hastalıklarda Görüntüleme. Şahap S, Fitoz F. Kalıtsal Hastalıklarda Radyolojik Görüntüleme.Türkiye Klinikleri.2021: 94-109.

Imaging of Tuberous Sclerosis Complex: A Pictorial Review. Von Ranke FM, Faria IM, Zanetti G, Hochhegger B,Souza AS, Marchiori E. 2017: Radiol Bras,48-54.

Phakomatoses: What Every Radiologist Should Know. Fuante CR, Aizpurua JE, Chato RP. 2014, ESR EPOS (Electronic Presentation Online System.)

Sturge-Weber Syndrome. In:Vinken PJ, Bruyn GW . GL, Alexander. 1972: Handbook Of Clinical Neurology: The Phakomatoses, 223-40.

Prospective Natural History Study of Central Nervous System Hemangioblastomas In Von Hippel-Lindau Disease. Lonser RR, Butman JA, Huntoon K, Asthagiri Arr, Wu T, Bakhtian KD:2014, J Neurosurg, 1055-62.

Tumors In Von Hippel-Lindau Syndrome:From Head to Toe-Comprehensive State-Ofthe Art Review. Ganeshan D, Menias CO, Pickhardt PJ, Sandrasegaran K,Lubner MG, Ramalingam P. 2018:Radiographics., 849-66.